Irina V. Kholodenko
Moscow, MOW 119121, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
GD2-Targeted Minibody-Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model.
Journal: International journal of molecular sciences
Published: January 19, 2026
Effect of Endocytosis Inhibitors on the Cytotoxicity and Antitumor Activity of Anti-GD2 ADCs.
Journal: Acta naturae
Published: December 08, 2025
Contrasting Impacts of Targeted Disruption of the Cancer Stem Cell Marker CD133 and Its Epigenetic Regulator TRIM28 in Colorectal Cancer Cells.
Journal: International journal of molecular sciences
Published: September 29, 2025
Endocytosis Properties of GD2-Specific Antibodies in Tumor Cells.
Journal: Biochemistry. Biokhimiia
Published: May 14, 2025
Optimization of Mitotic Index Quantification Using the Amnis ImageStream Imaging Flow Cytometer.
Journal: Bulletin of experimental biology and medicine
Published: May 07, 2025
Transcriptome-Wide Analysis of Pituitary and Ectopic Adrenocorticotropic Hormone-Secreting Tumors.
Journal: Cancers
Published: December 10, 2024
Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue.
Journal: International journal of molecular sciences
Published: October 31, 2024
Generation of Cell Models with Stable Expression of a Caspase-3 Activity Fluorescent Sensor.
Journal: Bulletin of experimental biology and medicine
Published: March 12, 2024
Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis.
Journal: Biomedicines
Published: October 15, 2023
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress.
Journal: International journal of molecular sciences
Published: September 23, 2023
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.
Journal: Current issues in molecular biology
Published: August 28, 2023
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.
Journal: International journal of molecular sciences
Published: November 29, 2022
Last Updated: 09/26/2026